Nalaganje...
The impact of co-administration of ketoconazole and rifampicin on the pharmacokinetics of apremilast in healthy volunteers
AIMS: Two clinical studies were conducted to determine possible drug−drug interactions between apremilast and a strong CYP3A4 inhibitor, ketoconazole, or a potent CYP3A4 inducer, rifampicin. The main objectives of these two studies were to evaluate the impact of multiple doses of ketoconazole on the...
Shranjeno v:
| izdano v: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BlackWell Publishing Ltd
2014
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4238785/ https://ncbi.nlm.nih.gov/pubmed/24962564 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12448 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|